Phase III clinical trial of COVAXIN shows 81 per cent efficacy COVAXIN has been developed on the WHO pre-qualified verocell platform, which is globally recognised with a well-established track…
ICMR initiates community-based serosurvey in 69 districts The survey collection already started in two districts of the Uttar Pradesh and one district in Assam
